Backing Nordic founders who are redefining patient care
We are looking for companies that are raising their first
professional rounds EOY 2025 or sometime in 2026
Got a deck?👇
Great MedTech founders consistently get these five pillars right.
That’s why LIFA Ventures uses them as both criteria and a guiding framework across everything we do - from the first meetings to follow-on decisions.
Smart MedTech founders start with clinical relevance, not just innovation. We look for founders who validate the unmet need early, engaging clinicians, patients, and payers to confirm both the pain point and the willingness to adopt. Market validation isn't about surveys; it's about evidence that your solution can improve outcomes and economics - not just locally, but globally.
Knowing how your product reaches patients is as important as the technology itself. We assess each company's strategy for pricing, distribution, and reimbursement - understanding who pays, who prescribes, and who benefits. The go-to-market pathway must reflect real-world workflows and health-economic logic. Early traction, pilots, and payer conversations turn clinical proof into commercial reality.
Product development in MedTech is never linear. We value founders who treat design, verification, and validation as a continuous learning loop - balancing speed with compliance. Early QMS building, clear development plans, milestone discipline, and data-driven iteration signal execution strength. Every iteration should move the device closer to market readiness, not just technical completion.
Winning in MedTech means designing with regulation in mind from day one. We invest in teams that understand their device classification, evidence requirements, and intended claims. A credible QMS, early FDA Q-Sub or NB dialogue, and well-defined clinical endpoints are key signals of a team ready for scale. Smart regulatory planning isn’t bureaucracy, it’s strategy based on your GTM pathway.
IP is more than patents, it’s your moat, your leverage, and your long-term value. We look for founders who align their IP strategy with their business model - covering not just the core technology, but key processes, data, and software layers. A strong freedom-to-operate analysis and active filing plan set apart teams who are building defensible MedTech companies, not just good ideas.
